Saturday, February 4, 2023

This is what happens when you stop using weight loss drugs

obesity It is one of the most frequent diseases in the world, causing countless negative consequences for health, such as heart disease, diabetes, hypertension, stroke, gallbladder disease, etc.

For this reason, a variety of treatment options such as diet, exercise, and surgery have been sought as a product of modern medicine.

they have also made many Medicines that can help treat obesityBut when they leave them, they bring them with them side effects such as rebound, i.e. weight gain that was reduced during treatment and some,

This class of drugs, marketed under the names Victoza and Ozempic, was initially used to treat type 2 diabetes and has gained popularity as an option for treating obesity.

These are known as GLP-1 RAs, help people produce insulin and lower blood sugar, and are given as a daily or weekly injection.

First approved by the US Food and Drug Administration in 2005 for use in patients with type 2 diabetes, the drugs were quickly seen to promote weight loss.

In 2014, the FDA approved GLP-1ARs for chronic weight management, and additional drugs have been approved in the weight loss class.

What Happens If Weight Loss Drugs Are Skipped?

Director of obesity medicine at Cedars-Sinai Medical Center, Dr. Amanda Velazquez notes that “obesity is a chronic, relapsing disease,” and the weight loss effects of drugs wear off after they are stopped.

Another expert, Dr. Domenica Rubino, director of the Washington Center for Weight Management and Research in Arlington, Virginia, said that Weight gain in people who stop taking the drug is “understandable.”

Rubino led a 2021 study, published in the Journal of the American Medical Association, that found people who took Vagovi regained two-thirds of their weight when they stopped the drug.

People who stop taking the drug may have their appetite back.The level he experienced before taking it. In some cases, she said, your appetite may feel bigger than it did before you started losing weight.

Off-label use of these drugs may have contributed to intermittent shortages of various doses of Ozempic and Vegovy. The pharmaceutical company Novo Nordisk, which makes Ozempic, Victoza and Vygovy, notes that “it is up to the clinical judgment of each healthcare provider to select the best treatment approach for their patients.”

A recent study from the University of Montpellier published in Diabetes Care looked at patients with type 2 diabetes who were treated with GLP-1 RAs between 2006 and 2018 and found an association between long-term use of these drugs and a higher chance of problems. Identified the link. Thyroid and Cancer.

We recommend you read:

Although this finding is concerning, it is important to note that studies have not yet determined whether there is a causal relationship between the use of these drugs and the above health problems.

Nation World News Desk
Nation World News Desk
Nation World News is the fastest emerging news website covering all the latest news, world’s top stories, science news entertainment sports cricket’s latest discoveries, new technology gadgets, politics news, and more.
Latest news
Related news


Please enter your comment!
Please enter your name here